Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Implication of p53 in base excision DNA repair: in vivo evidence

Abstract

The tumor suppressor p53 plays an important role in response to DNA damage, including DNA repair. One DNA repair pathway, nucleotide excision repair (NER), has been well-documented to be regulated by p53. It seemed probable that p53 may affect other DNA repair pathways. We employed matched isogenic pairs of cell lines, wild-type or p53-deficient, to investigate this question using methyl methanesulfonate (MMS), a base-damaging agent. Alkylation damage induced by MMS is repaired exclusively by the base excision repair (BER) pathway. Cells carrying mutant or no p53 genes exhibited slow BER of MMS-induced DNA damage, and exhibited MMS-sensitivity. One contributing factor is the abundance of DNA polymerase β (β-pol), an enzyme required for BER, which was almost absent in p53 mutant and p53-null cells. Our findings demonstrate an in vivo requirement for p53 in regulating the base excision repair response, a novel finding of great potential importance in understanding the DNA repair branch of the p53 pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Abbreviations

MMS:

methyl methanesulfonate

BER:

base excision repair

AP:

apurinic site

APE:

apurinic/apyrimidinic endonuclease

β-pol:

DNA-polymerase beta

References

  • Brown JM, Wouters BG . 1999 Cancer Res. 59: 1391–1399

  • Collins AR, Ma A-G, Duthie SJ . 1995 Mut. Res. 336: 69–77

  • Evans AR, Limp-Foster M, Kelley MR . 2000 Mutat Res. 461: 83–108

  • Fan S, Smith ML, Rivet DJ, Duba D, Zhan Q, Kohn KW, Fornace Jr AJ, O'Connor PM . 1995 Cancer Res. 55: 1649–1654

  • Ford JM, Hanawalt PC . 1995 Proc. Natl. Acad. Sci. USA 92: 8876–8880

  • Ford JM, Hanawalt PC . 1997 J. Biol. Chem. 272: 28073–28080

  • Fortini P, Pascucci B, Belisario F, Dogliotti E . 2000 Nucleic Acids Res. 28: 3040–3046

  • Friedberg EC, Walker GC, Seide W . 1995 DNA Repair and Mutagenesis ASM Press: Washington, D.C

    Google Scholar 

  • Hawkins DS, Demers GW, Galloway DA . 1996 Cancer Res. 56: 892–898

  • Hollander MC, Anver M, Kim K, Fornace Jr AJ . 2001 Cancer Res. 61: 2487–2491

  • Hwang BJ, Ford JM, Hanawalt PC, Chu G . 1999 Proc. Natl. Acad. Sci. USA 96: 424–428

  • Jayaraman L, Murthy K, Zhu C, Curran T, Xanthoudakis S, Prives C . 1997 Genes Dev. 11: 558–570

  • Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace Jr AJ . 1992 Cell 71: 587–597

  • Klungland A, Hoss M, Gunz D, Constantinou A, Clarkson SG, Doetsch PW, Bolton PH, Wood RD, Lindahl T . 1999 Mol. Cell 3: 33–42

  • Lackinger D, Kaina B . 2001 Mutat. Res. 457: 113–123

  • Leveillard T, Andera L, Bissonnette N, Schaffer L, Bracco L, Egly JM, Wasylyk B . 1996 EMBO J. 15: 1615–1624

  • Matsumoto Y, Kim K, Hurwitz J, Gary R, Levin DS, Tomkinson AE, Park MS . 1999 J. Biol. Chem. 274: 33703–33708

  • Morris EJ, Dreixler JC, Cheng CY, Wilson PM, Gin RM, Geller HM . 1998 Biotechniques 26: 282–289

  • Offer H, Zurer I, Banfalvi G, Reha'k M, Falcovitz A, Milyausky M, Goldfinger N, Rotter V . 2001a Cancer Res. 61: 88–96

  • Offer H, Milyavsky M, Erez N, Matas D, Zurer I, Harris CC, Rotter V . 2001b Oncogene 20: 581–589

  • Okorokov AL, Milner J . 1999 Mol. Cell. Biol. 19: 7501–7510

  • Seo YR, Chen E, Smith ML . 2001 Breast Cancer Res. Treat. in press

  • Smith ML, Chen IT, Zhan Q, O'Connor PM, Fornace Jr AJ . 1995 Oncogene 10: 1053–1059

  • Smith ML, Ford JM, Hollander MC, Bortnick RA, Amundson SA, Seo YR, Deng C, Hanawalt PC, Fornace Jr AJ . 2000 Mol. Cell. Biol. 20: 3705–3714

  • Sobol RW, Prasad R, Evenski A, Baker A, Yang XP, Horton JK, Wilson SH . 2000 Nature 405: 807–810

  • Stucki M, Pascucci B, Parlanti E, Fortini P, Wilson SH, Hubscher U, Dogliotti E . 1998 Oncogene 17: 835–843

  • Tokino T, Thiagalingam S, el-Deiry WS, Waldman T, Kinzler KW, Vogelstein B . 1994 Hum. Mol. Genet. 3: 1537–1542

  • Wilson SH, Kunkel TA . 2000 Nat. Struct. Biol. 7: 176–178

  • Zhou J, Ahn J, Wilson SH, Prives C . 2001 EMBO J. 20: 914–923

Download references

Acknowledgements

We thank David W O'Hannesian, Lindsey D Mayo, and two anonymous reviewers for their insightful comments on the manuscript. This work was supported by Indiana University Cancer Center and American Cancer Society grants 1RG84-002 and RSG-02-028-01-CNE (ML Smith).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seo, Y., Fishel, M., Amundson, S. et al. Implication of p53 in base excision DNA repair: in vivo evidence. Oncogene 21, 731–737 (2002). https://doi.org/10.1038/sj.onc.1205129

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205129

Keywords

This article is cited by

Search

Quick links